OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
YB$14.0757

Yuanbao Inc

Life & Health InsuranceVerified

Yuanbao Inc's capital structure shows no dilution risk with identical basic and diluted shares outstanding of 46,080,201. The company's market capitalization of 648.35 million CNY reflects a market price of 14.07 CNY per share. However, liquidity risk cannot be assessed due to missing balance-sheet inputs and lack of going-concern language in source documents. Profitability metrics are unavailable for comparison against industry benchmarks. The company's risk assessment indicates low dilution potential but no data exists to evaluate returns on invested capital or operating margins relative to Life & Health Insurance peers. Segment and geographic exposure data is not disclosed in available filings. The company operates in China's insurance market but revenue concentration by product line or region remains unspecified. Growth trajectory analysis is constrained by limited historical data. Analysts have assigned a single "Hold" recommendation with no price target dispersion (all 21.80 CNY). This suggests limited consensus on valuation direction. Risk factors include unassessable liquidity risk and lack of balance-sheet transparency. The company has not disclosed any capital structure adjustments or dilution events in available data. Recent filings show no material events affecting operations or capital structure. The single analyst recommendation reflects cautious positioning without strong buy/sell signals.

30-day price · YB-5.08 (-28.6%)
Low$12.67High$19.00Close$12.70As of22 May, 00:00 UTC
Profile
CompanyYuanbao Inc
TickerYB.O
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. Yuanbao Inc provides life and health insurance products and services in China.

Classification. Yuanbao Inc is classified in the Financials economic sector, Insurance business sector, and Life & Health Insurance industry with 92% confidence.

Yuanbao Inc's capital structure shows no dilution risk with identical basic and diluted shares outstanding of 46,080,201. The company's market capitalization of 648.35 million CNY reflects a market price of 14.07 CNY per share. However, liquidity risk cannot be assessed due to missing balance-sheet inputs and lack of going-concern language in source documents. Profitability metrics are unavailable for comparison against industry benchmarks. The company's risk assessment indicates low dilution potential but no data exists to evaluate returns on invested capital or operating margins relative to Life & Health Insurance peers. Segment and geographic exposure data is not disclosed in available filings. The company operates in China's insurance market but revenue concentration by product line or region remains unspecified. Growth trajectory analysis is constrained by limited historical data. Analysts have assigned a single "Hold" recommendation with no price target dispersion (all 21.80 CNY). This suggests limited consensus on valuation direction. Risk factors include unassessable liquidity risk and lack of balance-sheet transparency. The company has not disclosed any capital structure adjustments or dilution events in available data. Recent filings show no material events affecting operations or capital structure. The single analyst recommendation reflects cautious positioning without strong buy/sell signals.
Key takeaways
  • Yuanbao Inc shows no dilution risk with identical basic and diluted share counts
  • Analysts have issued a single "Hold" recommendation with no price target dispersion
  • Liquidity risk cannot be assessed due to missing balance-sheet data
  • No segment or geographic revenue breakdown is disclosed in available filings
  • The company's market capitalization is 648.35 million CNY at current share price
  • # RATIONALES
  • {
  • "margin_outlook_rationale": "Unable to assess margin outlook due to missing profitability data in source documents",
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Valuation
Market price$14.07
Market cap$648.3M
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
MetricYBActivity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity27.5% medp25 4.7% · p75 66.5%
Observations
IR observations
Mean price target21.80 CNY
Median price target21.80 CNY
High price target21.80 CNY
Low price target21.80 CNY
Mean recommendation3.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count0.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate4.36 CNY
Last actual EPS4.15 CNY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-25 04:43 UTC#c34a12ce
Source: analysis-pipeline (hybrid)Generated: 2026-05-30 02:27 UTCJob: bcb41908